Medicare Enrolled

Dr. Daniel Nieves-Quinones, M.D.

Optician · Maitland, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
301 N MAITLAND AVE, Maitland, FL 32751
4076475996
In practice since 2005 (20 years)
NPI: 1194714634 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nieves-Quinones from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nieves-Quinones? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nieves-Quinones

Dr. Daniel Nieves-Quinones is an optician in Maitland, FL, with 20 years in practice. Based on federal Medicare data, Dr. Nieves-Quinones performed 15,682 Medicare services across 1,126 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nieves-Quinones received a total of $37,921 from 92 pharmaceutical and/or device companies across 1319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nieves-Quinones is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in FL$ $37,921 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,682
Medicare services
Top 5% in FL for optician
1,126
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~784 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit14,089$5$11
Office visit, established patient (30-39 min)825$89$170
Office visit, established patient (20-29 min)138$59$112
New patient office visit, complex (60-74 min)133$158$316
Needle measurement of electrical activity in arm or leg muscles, complete study115$73$385
New patient office visit (45-59 min)90$123$250
Office visit, established patient, complex (40-54 min)55$135$241
Nerve conduction, 5-6 studies54$98$1,263
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face50$115$300
EEG, extended monitoring35$333$573
Needle measurement of electrical activity in arm or leg muscles, limited study21$45$229
Nerve conduction, 7-8 studies18$130$1,684
Measurement of brain wave activity (eeg), continuous16$203$275
Measurement of brain wave activity (eeg), 12-26 hours16$122$175
Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report16$124$200
Nerve conduction, 9-10 studies11$163$2,105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$37,921
Total received (2018-2024)
Avg $5,417/year across 7 years
Top 5% in FL for optician
92
Companies
1,319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,687 (62.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,234 (37.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,924
2023
$3,369
2022
$3,104
2021
$7,837
2020
$11,141
2019
$4,456
2018
$3,091

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$9,757
AbbVie Inc.
$3,224
Biogen, Inc.
$1,687
ABBVIE INC.
$1,493
LivaNova USA, Inc.
$1,385
GENZYME CORPORATION
$1,179
Alexion Pharmaceuticals, Inc.
$1,027
UCB, Inc.
$1,007
BANNER LIFE SCIENCES, LLC
$959
Neurocrine Biosciences, Inc.
$936
Teva Pharmaceuticals USA, Inc.
$896
Lundbeck LLC
$896
Lilly USA, LLC
$877
EMD Serono, Inc.
$843
ARGENX US, INC.
$645
Eisai Inc.
$642
Allergan Inc.
$594
Amgen Inc.
$487
Novartis Pharmaceuticals Corporation
$437
Acorda Therapeutics, Inc
$403
Celgene Corporation
$383
Supernus Pharmaceuticals, Inc.
$372
Horizon Therapeutics plc
$336
Amneal Pharmaceuticals LLC
$321
Genentech USA, Inc.
$315
Janssen Pharmaceuticals, Inc
$279
US WorldMeds, LLC
$270
JAZZ PHARMACEUTICALS INC.
$260
SK Life Science, Inc.
$252
ACADIA Pharmaceuticals Inc
$244
PFIZER INC.
$235
Grifols USA, LLC
$231
Biohaven Pharmaceuticals, Inc.
$228
CATALYST PHARMACEUTICALS, INC.
$221
MITSUBISHI TANABE PHARMA AMERICA, INC.
$207
Jazz Pharmaceuticals Inc.
$195
Alnylam Pharmaceuticals Inc.
$193
Otsuka America Pharmaceutical, Inc.
$184
Mallinckrodt Hospital Products Inc.
$183
Neurelis, Inc.
$168
Takeda Pharmaceuticals U.S.A., Inc.
$159
EISAI INC.
$156
NOVARTIS PHARMACEUTICALS CORPORATION
$155
Biohaven Pharmaceutical Holding Company Ltd.
$154
Mallinckrodt LLC
$154
Mallinckrodt Enterprises LLC
$142
MDD US Operations, LLC
$142
Avanir Pharmaceuticals, Inc.
$141
Impax Laboratories, Inc.
$140
Harmony Biosciences LLC
$123
UPSHER-SMITH LABORATORIES LLC
$119
Sumitomo Pharma America, Inc.
$113
SCILEX PHARMACEUTICALS INC.
$107
CSL Behring
$92
GE HEALTHCARE
$85
Greenwich Biosciences, Inc.
$80
Avadel CNS Pharmaceuticals, LLC
$77
Bausch Health US, LLC
$75
HARMONY BIOSCIENCES LLC
$73
Kyowa Kirin, Inc.
$68
ARBOR PHARMACEUTICALS, INC.
$58
Assertio Therapeutics, Inc.
$57
Strongbridge US INC.
$57
Scilex Pharmaceuticals Inc.
$56
TG THERAPEUTICS, INC.
$54
Averitas Pharma Inc.
$53
Merz Pharmaceuticals, LLC
$52
Catalyst Pharmaceuticals, Inc.
$51
Banner Life Sciences, LLC
$49
Zyla Life Sciences
$45
E.R. Squibb & Sons, L.L.C.
$45
Adamas Pharmaceuticals, Inc.
$44
Vanda Pharmaceuticals Inc.
$44
Xeris Pharmaceuticals, Inc.
$43
Bayer HealthCare Pharmaceuticals Inc.
$40
Ipsen Biopharmaceuticals, Inc
$37
Sandoz Inc.
$31
AbbVie, Inc.
$28
Currax Pharmaceuticals LLC
$26
Egalet US Inc
$26
IMPEL PHARMACEUTICALS INC.
$23
Cala Health, Inc.
$21
MERZ NORTH AMERICA, INC.
$20
Avion Pharmaceuticals
$20
Mylan Specialty L.P.
$20
Merck Sharp & Dohme LLC
$19
Abbott Laboratories
$19
Medtronic, Inc.
$18
Zyla Life Sciences, Inc.
$15
Medtronic Vascular, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Arbor Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.7% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CALA TRIO · CAMBIA · CONTRAVE · CREXONT · Cambia · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Edarbyclor · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fabhalta · Fycompa · GAMMAGARD · GENERAL DBS · GOCOVRI · GVOKE PFS · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LUMRYZ · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · PONVORY · PROCLAIM · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRAVATO · SPRIX · SUNOSI · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZORVOLEX · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for optician in FL.

Equivalent to $242 per 100 Medicare services performed
Looking for a optician in Maitland?
Compare opticians in the Maitland area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
338
Per 100K population
23.5
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
5.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nieves-Quinones is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (low-engagement, top 5%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nieves-Quinones experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Nieves-Quinones performed 14,089 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nieves-Quinones receive payments from pharmaceutical companies?
Yes. Dr. Nieves-Quinones received a total of $37,921 from 92 companies across 1,319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nieves-Quinones's costs compare to other opticians in Maitland?
Dr. Nieves-Quinones's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nieves-Quinones) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →